Wednesday, 25 March 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 25 March 2026
News

New Horizon for Aussie research

Posted 25 March 2026 PM

The landmark Australia-European Union Free Trade Agreement will see Australia join Europe's flagship research and innovation program, earning praise from Medicines Australia (MA).

The industry organisation has joined a host of others - including researchers - celebrating the agreement, which will see Australians gain access to Horizon Europe funding and projects, currently with a budget of around $159 billion (95.5 billion euros) over seven years.

To see the whole article, please login

Popular

Where Drs say pharma falls short
Ex-J&J staffer sued for secrets 'theft'
Fresh fallout from PBAC rejections
PBS giant hangs on tight
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home